Baxter/$BAX
14:30
10:10
05:45
01:25
21:00
1D1W1MYTD1Y5YMAX
About Baxter
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Ticker
$BAX
Sector
Primary listing
NYSE
Employees
38,000
Headquarters
Website
Baxter Metrics
BasicAdvanced
$9.2B
-
-$0.67
0.61
$0.68
3.79%
Price and volume
Market cap
$9.2B
Beta
0.61
52-week high
$37.74
52-week low
$17.47
Average daily volume
7.2M
Dividend rate
$0.68
Financial strength
Total debt to equity
133.347
Interest coverage (TTM)
3.23%
Profitability
EBITDA (TTM)
2,228
Gross margin (TTM)
37.93%
Net profit margin (TTM)
-3.09%
Operating margin (TTM)
9.86%
Effective tax rate (TTM)
-30.74%
Revenue per employee (TTM)
$290,000
Management effectiveness
Valuation
Price to revenue (TTM)
0.835
Price to book
1.26
Price to tangible book (TTM)
-3.05
Dividend yield (TTM)
3.79%
Forward dividend yield
3.79%
Growth
Revenue change (TTM)
3.90%
Earnings per share change (TTM)
-414.42%
3-year revenue growth (CAGR)
-8.26%
10-year revenue growth (CAGR)
0.82%
3-year earnings per share growth (CAGR)
-47.96%
10-year earnings per share growth (CAGR)
-14.32%
3-year dividend per share growth (CAGR)
-15.82%
10-year dividend per share growth (CAGR)
-8.62%
What the Analysts think about Baxter
Analyst ratings (Buy, Hold, Sell) for Baxter stock.
Baxter Financial Performance
Revenues and expenses
Baxter Earnings Performance
Company profitability
Baxter News
AllArticlesVideos
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International
Business Wire4 hours ago
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
Newsfile Corp21 hours ago
Baxter Trims Annual Outlook Again, Stock Hits 52-Week
Benzinga1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Baxter stock?
Baxter (BAX) has a market cap of $9.2B as of November 06, 2025.
What is the P/E ratio for Baxter stock?
The price to earnings (P/E) ratio for Baxter (BAX) stock is 0 as of November 06, 2025.
Does Baxter stock pay dividends?
Yes, the Baxter (BAX) stock pays dividends to shareholders. As of November 06, 2025, the dividend rate is $0.68 and the yield is 3.79%. Baxter has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Baxter dividend payment date?
The next Baxter (BAX) dividend payment date is unconfirmed.
What is the beta indicator for Baxter?
Baxter (BAX) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.